Clinical trials
Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 26 |
| National Cancer Institute (NCI) | 4 |
| Novartis Pharmaceuticals | 4 |
| Therapeutic Advances in Childhood Leukemia Consortium | 4 |
| Amgen | 3 |
| Bristol-Myers Squibb | 3 |
| AbbVie | 2 |
| Accenture | 1 |
| Allotera Therapeutics | 1 |
| Charite University, Berlin, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 58 |
| Leukemia | 22 |
| Recurrence | 8 |
| Burkitt Lymphoma | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Lymphoma | 5 |
| Leukemia, Biphenotypic, Acute | 4 |
| Leukemia, Myelomonocytic, Juvenile | 4 |
| Lymphoma, Non-Hodgkin | 4 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.